Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

$VORPress releaseOct 5, 2026, 6:00 PM ETRead the release

Vor Bio granted inducement stock options on 59,250 shares and RSUs on 12,550 shares to 9 newly hired employees under its 2023 Inducement Plan. The options carry a $18.06 exercise price equal to the grant-date close, with standard four-year vesting (25% at 12 months, remainder monthly/quarterly).

Key figures

Rsu shares
12550
Option shares
59250
Exercise price
18.06
Employees granted
9

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.